A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/10 (2006.01) A61K 9/107 (2006.01) A61K 9/127 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2682493
Disclosed are a novel therapeutic agent and a novel treatment method for cancer. Specifically disclosed are: a targeting agent for a cell selected from the group consisting of a cancer cell and a cancer-associated fibroblast, which comprises a retinoid; a substance delivery carrier for the cell, which comprises the targeting agent; an anti-cancer composition utilizing the targeting agent or the carrier; an anti cancer-associated fibroblast composition; and a method for treatment of cancer.
L'invention concerne un nouvel agent thérapeutique et un nouveau procédé de traitement du cancer. L'invention concerne spécifiquement un agent de ciblage d'une cellule sélectionnée dans le groupe constitué d'une cellule cancéreuse et d'un fibroblaste associé à un cancer, qui comprend un rétinoïde ; un vecteur de délivrance de substance dans la cellule, qui comprend l'agent de ciblage ; une composition anticancéreuse utilisant l'agent de ciblage ou le vecteur ; une composition de fibroblastes associés anticancéreuse ; et un procédé de traitement du cancer.
Niitsu Yoshiro
Takimoto Rishu
Mbm Intellectual Property Law Llp
Nitto Denko Corporation
LandOfFree
Targeting agent for cancer cell or cancer-associated fibroblast does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting agent for cancer cell or cancer-associated fibroblast, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting agent for cancer cell or cancer-associated fibroblast will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1839729